PROVEXIS PLC Logo

PROVEXIS PLC

Develops and licenses functional ingredients for the food and supplement markets.

PXS | IL

Overview

Corporate Details

ISIN(s):
GB00B0923P27
LEI:
21380042E3Y3N9VZ6N48
Country:
United Kingdom
Address:
2 BLAGRAVE STREET, RG1 1AZ READING

Description

Provexis PLC is a life sciences company that develops, licenses, and commercializes functional ingredients for the global food, beverage, and dietary supplement markets. The company's principal technology is Fruitflow®, a patented, scientifically-proven bioactive ingredient derived from tomatoes. Fruitflow® is designed to support cardiovascular health by helping to maintain normal blood platelet aggregation, which contributes to healthy blood flow. Provexis licenses its technology to business partners for inclusion in their consumer products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-21 14:50
Result of AGM
English 23.8 KB
2025-10-30 08:00
Final Results
English 388.4 KB
2025-09-30 09:40
Delay in publication of annual accounts
English 18.0 KB
2025-01-07 14:14
Grant of Options and Warrants
English 32.6 KB
2024-12-31 14:00
Total Voting Rights
English 13.8 KB
2024-12-31 10:59
Half-year Report
English 212.7 KB
2024-12-18 08:00
Purchase of Fruitflow® II SD & royalty payment
English 18.8 KB
2024-10-25 16:47
Result of AGM
English 24.2 KB
2024-09-30 08:00
Final Results
English 384.9 KB
2024-04-30 18:00
Total Voting Rights
English 13.7 KB
2024-03-28 08:00
Issue of Equity - purchase of Fruitflow® II SD
English 18.8 KB
2023-12-29 13:48
Half-year Report
English 198.4 KB
2023-10-26 14:51
Result of AGM
English 23.8 KB
2023-09-29 08:00
Final Results
English 374.8 KB
2023-08-30 08:04
BYHEALTH regulatory filing with Chinese SAMR
English 16.5 KB

Automate Your Workflow. Get a real-time feed of all PROVEXIS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PROVEXIS PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PROVEXIS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Avalo Therapeutics, Inc. Logo
Clinical-stage biotech developing treatments for immune-mediated inflammatory diseases.
United States of America
AVTX
Azenta, Inc. Logo
Offers sample management, storage, and multiomics solutions for life sciences.
United States of America
AZTA
BenevolentAI Logo
Applies artificial intelligence to accelerate drug discovery and development.
United Kingdom
BAI
bioAffinity Technologies, Inc. Logo
Develops noninvasive diagnostics and targeted therapeutics for cancer.
United States of America
BIAF
BioArctic Logo
Biopharmaceutical firm developing antibody therapies for neurodegenerative diseases.
Sweden
BIOA
BioInfra Co.,Ltd. Logo
Develops multi-biomarker blood tests for early cancer screening and gene treatments.
South Korea
199730
BioInfra Life Science Inc. Logo
Develops multi-biomarker blood tests for early cancer screening and gene treatments.
South Korea
266470
BioNexus Gene Lab Corp Logo
Develops gene-based diagnostics for early detection of disease susceptibility.
United States of America
BGLC
Biophytis S.A. Logo
Clinical-stage biotech developing therapeutics for age-related degenerative diseases.
France
ALBPS
BioRestorative Therapies, Inc. Logo
Develops adult stem cell therapies for degenerative disc and metabolic disorders.
United States of America
BRTX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.